Summary & Overview
CPT 81256: HFE (Hemochromatosis) Gene Technical Laboratory Test
CPT code 81256 covers the technical laboratory test to detect common variants in the HFE gene associated with hereditary hemochromatosis. As a molecular diagnostic service, it is performed in clinical or hospital laboratories and supports diagnosis, carrier detection, and management planning for patients with iron overload or suspected hereditary hemochromatosis. Nationally, genetic testing for HFE variants is an established component of diagnostic pathways for iron metabolism disorders and has implications for clinical decision-making and cascade screening.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage and reimbursement benchmarks, common billing and documentation considerations, and clinical context for when HFE genetic testing is typically ordered. The publication outlines typical sites of service and describes the technical nature of CPT code 81256, clarifying its role relative to specimen processing and laboratory analytic procedures.
This summary provides clinicians, laboratory administrators, and billing professionals with concise information about the code’s clinical relevance, payer landscape, and the types of benchmarks and policy topics covered in the full publication. Data not available in the input is noted where applicable in the detailed sections.
Billing Code Overview
CPT code 81256 describes a molecular diagnostic laboratory test performed by a lab analyst to detect the presence of common changes in the hemochromatosis gene, also known as HFE. This service represents the technical laboratory component of HFE gene testing to identify common pathogenic variants associated with hereditary hemochromatosis.
Service type: Genetic molecular diagnostic testing (technical component).
Typical site of service: Clinical laboratory or hospital laboratory performing molecular diagnostics.
Clinical & Coding Specifications
Clinical Context
A 45-year-old adult with a family history of hereditary hemochromatosis is referred by a primary care physician for targeted genetic testing to evaluate common pathogenic HFE gene variants. The patient has borderline elevated serum ferritin and transferrin saturation on screening labs, prompting genetic confirmation. A blood sample is collected in an outpatient phlebotomy or clinical laboratory setting, labeled, and sent to a molecular diagnostics laboratory. The laboratory technologist performs the technical assay to detect common HFE gene changes (for example, the C282Y and H63D variants). Results are reviewed by a laboratory director or geneticist, reported in the electronic medical record, and communicated to the ordering clinician for interpretation and potential cascade testing of relatives.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional (interpretive) component if separated billing applies and the laboratory charges separately for interpretation. |
TC | Technical component | Use when reporting only the technical component (laboratory processing, equipment) when billed separately from interpretation. |